THURSDAY, DECEMBER 8, 2016

PharmiWeb


PharmiWeb News

Walgreens releases latest data on flu activity

Walgreens released its most recent flu index for the week that began on Dec. 29. Read More »

AHF favors cheaper Hepatitis C treatment

The AIDS Healthcare Foundation (AHF) praised a decision by Express Scripts Holding Co. on Monday to drop a higher priced Hepatitis C treatment in favor of AbbVie Inc.'s cheaper Viekira Pak treatment option. Read More »

Walgreens Flu Index shows flu rising in the South

Texas had the highest influenza incidences for the week ending Dec. 19, topping Walgreens' Flu Index report. Read More »

EB Pharma-Janssen deal on hepatitis D drug allows human trials

EB Pharma, LLC, said recently that it has entered into an agreement with Janssen Pharmaceutica NV for an exclusive license to use tipifarnib, a potential Hepatitis D (HDV) drug, in clinical trials. Read More »

Canopus BioPharma sees positive results in Ebola treatment study

Canopus BioPharma, Inc. recently released positive results from a study that tested the effectiveness of a prescription drug treatment for Ebola called CB008. Read More »

14 arrests made in NECC-connected meningitis outbreak from 2012

Federal law enforcement officials on Wednesday arrested 14 owners and employees of New England Compounding Center on several charges stemming from the deadly 2012 fungal meningitis outbreak. Read More »

Ukraine TB outbreak has potential to be full-blown epidemic

Ukraine is going through a tuberculosis outbreak and one organization believes it could have been avoided. Read More »

Ablynx seeks infant, toddler RSV trial subjects

Ablynx, a biopharmaceutical company, recently announced that it is accepting infant- and toddler-aged subjects for a Phase IIa study of ALX-0171, an anti-Respiratory Syncytial Virus (RSV) Nanobody treatment. Read More »

Walgreens Flu Index has latest statistics on flu activity in U.S.

The Walgreens Flu Index for the week ending Dec. 12, 2014, shows the latest statistics for designated market areas where cases of the flu are increasing and decreasing. Read More »

Pharmaceutical companies collaborate on new Ebola drug

CMC Biologics and OncoSynergy agreed on Tuesday to collaborate on the development and manufacturing of OS2966 as a potential Ebola treatment. Read More »

Arrowhead submits FDA application for hep B treatment

Arrowhead Research Corporation, a biopharmaceutical company specializing in creating targeted RNAi therapies, recently submitted an application to the U.S. Food and Drug Administration (FDA) for further testing of a new drug, called ARC-520, to treat chronic hepatitis B virus infection. Read More »

Researchers create potential HIV vaccine candidate

A team of Seattle researchers led by Dr. Leo Stamatatos recently created an HIV vaccine candidate that could induce the immune system to defend against a wide range of HIV strains. Read More »

Integral Molecular IDs human antibodies that fight Chikungunya virus

Integral Molecular may have found a way for the body to fight the mosquito-borne Chikungunya virus (CHIKV). Read More »

PaxVax will seek FDA approval of single-dose cholera vaccine

PaxVax, Inc. announced positive results today from a Phase 3 trial of its oral cholera vaccine candidate PXVX0200. Read More »

Research into hantavirus treatments shows purified antibodies can protect against disease

SAB Biotherapeutics, Inc., (SAB) and the U.S. Read More »

CDC awards grant to Meridian for rotavirus vaccine

The U.S. Centers for Disease Control and Prevention recently awarded a second Small Business Innovation Research contract to Meridian Life Science, Inc. to create a rotavirus vaccine. Read More »

Walgreens releases data showing flu rates

Walgreens (NYSE: WAG) (Nasdaq: WAG) recently released weekly data from its Flu Index that reveals specific areas within the United States where the flu is escalating the most. The data rates areas based on the number of influenza cases throughout the United States as well as the accumulative rate of cases from week to week. Read More »

MeadWestvaco receives grant for MEMS use in HIV/AIDS fight

MeadWestvaco Corporation (MWV) recently received a grant to provide the Bill & Melinda Gates Foundation with its Medication Event Monitoring System (MEMS) for use in a project to help prevent the spread of HIV/AIDS in Africa and India. Read More »

Xpert Norovirus test gets green light from FDA

Cepheid, a molecular diagnostics company, recently received clearance from the U.S Food and Drug Administration to market its Xpert Norovirus test. Read More »

Mylan enters agreement with Gilead to develop new HIV drug

Mylan Laboratories Limited reached an agreement with Gilead Sciences Inc. on Monday to manufacture and distribute Tenofovir Alafenamide, an experimental HIV medication. Read More »